119 related articles for article (PubMed ID: 1459817)
1. Prognostic variables in patients with prostate cancer: influence of blood group ABO (H), the Rhesus system, age, differentiation, tumour stage and metastases.
Kvist E; Krogh J; Hjortberg P
Int Urol Nephrol; 1992; 24(4):417-23. PubMed ID: 1459817
[TBL] [Abstract][Full Text] [Related]
2. AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.
Seebacher V; Polterauer S; Reinthaller A; Koelbl H; Achleitner R; Berger A; Concin N
BMC Cancer; 2018 Apr; 18(1):447. PubMed ID: 29673336
[TBL] [Abstract][Full Text] [Related]
3. Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey.
Akin S; Altundag K
Med Sci Monit; 2018 Jul; 24():4698-4703. PubMed ID: 29981282
[TBL] [Abstract][Full Text] [Related]
4. The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram.
Stokkel M; Zwinderman A; Zwartendijk J; Pauwels E; van Eck-Smit B
Eur J Nucl Med; 1997 Oct; 24(10):1215-20. PubMed ID: 9323261
[TBL] [Abstract][Full Text] [Related]
5. Significance of ABO-Rh blood groups in response and prognosis in breast cancer patients treated with radiotherapy and chemotherapy.
Cihan YB
Asian Pac J Cancer Prev; 2014; 15(9):4055-60. PubMed ID: 24935596
[TBL] [Abstract][Full Text] [Related]
6. ABO and rhesus blood groups as prognostic factors in transitional cell carcinomas of the upper urinary tract.
Krogh J; Kvist E
Urol Int; 1992; 48(1):9-13. PubMed ID: 1598741
[TBL] [Abstract][Full Text] [Related]
7. ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To 'B' or Not to 'B'.
Tam AA; Özdemir D; Fakı S; Bilginer MC; Ersoy R; Çakır B
Endocr Res; 2020; 45(2):137-146. PubMed ID: 31760829
[No Abstract] [Full Text] [Related]
8. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
9. Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey.
Urun Y; Utkan G; Cangir AK; Oksuzoglu OB; Ozdemir N; Oztuna DG; Kocaman G; Coşkun HŞ; Kaplan MA; Yuksel C; Demirkazik A; Icli F
Asian Pac J Cancer Prev; 2013; 14(5):2801-3. PubMed ID: 23803034
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer.
Slater G; Itzkowitz S; Azar S; Aufses AH
Dis Colon Rectum; 1993 Jan; 36(1):5-7. PubMed ID: 8416779
[TBL] [Abstract][Full Text] [Related]
11. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group.
Ürün Y; Utkan G; Yalcin Ş; Coşkun HŞ; Koçer M; Özdemir NY; Kaplan MA; Arslan ÜY; Özdemir F; Öztuna D; Akbulut H; İçli F
Asian Pac J Cancer Prev; 2012; 13(8):4129-31. PubMed ID: 23098529
[TBL] [Abstract][Full Text] [Related]
12. ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases.
Halvorsen TB
Scand J Gastroenterol; 1986 Oct; 21(8):979-83. PubMed ID: 3095914
[TBL] [Abstract][Full Text] [Related]
13. Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.
Allen FJ; de Kock ML; de Klerk DP; Heyns CF
S Afr J Surg; 1991 Mar; 29(1):15-8. PubMed ID: 1905062
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
15. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
[TBL] [Abstract][Full Text] [Related]
16. Frequency of ABO/Rhesus Blood Groups in Patients with Diabetes Mellitus.
Oner C; Dogan B; Telatar B; Celik Yagan CF; Oguz A
J Coll Physicians Surg Pak; 2016 Jan; 26(1):74-5. PubMed ID: 26787039
[TBL] [Abstract][Full Text] [Related]
17. [Stage M1b prostatic adenocarcinoma: prognostic factors, value of bone scintigraphy].
Rattier C; Rossi D; Coulange C; Rampal M; Serment G
Prog Urol; 1994 Dec; 4(6):984-99. PubMed ID: 7874187
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
19. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; Rouprêt M; Shariat SF
Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
[TBL] [Abstract][Full Text] [Related]
20. ABO and Rh blood groups distribution in patients with endometriosis.
Matalliotakis I; Cakmak H; Goumenou A; Sifakis S; Ziogos E; Arici A
Arch Gynecol Obstet; 2009 Dec; 280(6):917-9. PubMed ID: 19301022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
